{{Rsnum
|rsid=2045065
|Chromosome=4
|position=1058700
|Orientation=minus
|GMAF=0.2282
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=RNF212
|Gene_s=RNF212
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 64.6 | 28.3 | 7.1
| HCB | 46.7 | 42.3 | 10.9
| JPT | 27.4 | 58.4 | 14.2
| YRI | 95.9 | 4.1 | 0.0
| ASW | 87.7 | 12.3 | 0.0
| CHB | 46.7 | 42.3 | 10.9
| CHD | 42.2 | 43.1 | 14.7
| GIH | 62.4 | 32.7 | 5.0
| LWK | 94.5 | 5.5 | 0.0
| MEX | 46.6 | 34.5 | 19.0
| MKK | 89.7 | 10.3 | 0.0
| TSI | 52.0 | 42.2 | 5.9
| HapMapRevision=28
}}

{{omim
|desc=RECOMBINATION RATE QUANTITATIVE TRAIT LOCUS 1; RRQTL1
|id=612042
|rsnum=2045065
}}

{{PharmGKB
|RSID=rs2045065
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:18239089
|Annotation=This SNP is correlated with genome-wide recombination rate;opposite effects are observed in males and females.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Curated
|PharmGKB Accession ID=PA161416633
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2045065
|overall_frequency_n=108
|overall_frequency_d=128
|overall_frequency=0.84375
|n_genomes=54
|n_genomes_annotated=0
|n_haplomes=91
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}